Science & Medicine

HR-Positive Metastatic Breast Cancer — An Interview with Dr Erika Hamilton on the Potential Role of PROTAC Estrogen Receptor Degraders

Nov 20, 202558:36Science & Medicine

Dr Erika Hamilton from Sarah Cannon Research Institute in Nashville, Tennessee, reviews available clinical data with PROTAC estrogen receptor degraders and their potential role in the management of HR-positive metastatic...

About This Episode

HR-Positive Metastatic Breast Cancer — An Interview with Dr Erika Hamilton on the Potential Role of PROTAC Estrogen Receptor Degraders is an episode from Breast Cancer Update by Dr. Neil Love. Dr Erika Hamilton from Sarah Cannon Research In...

Podcast

This episode belongs to Breast Cancer Update.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Nov 20, 2025, 58:36 long, audio available.

HR-Positive Metastatic Breast Cancer — An Interview with Dr Erika Hamilton on the Potential Role of PROTAC Estrogen Receptor Degraders

About This Episode

Related Episodes